ipilimumab,capecitabine,leucovorin,oxaliplatin,nivolumab,fluorouracil
bms
['cm649', 'nivo']
cm649 3yr fu - os tail cps&gt;5 ~20%, but if response @ 18wk landmark, 33% alive nivo/chemo @ 3y vs 14% chemo. non-response @ 18wk do much worse. #asco23 
attempting to strike a balance between motherhood, medical oncology, immunology research and *life (*stuff that happens in between)